Howard Detwiler
Psychiatry · Anchorage, AKNPI 1649257460
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 183 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 33.1% of the total. Among psychiatry clinicians in AK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $26.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Neurocrine Biosciences, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$615
- Otsuka America Pharmaceutical, Inc.$494
- Axsome Therapeutics, Inc.$208
- Sunovion Pharmaceuticals Inc.$203
- plus $600 from 9 others
What the payments were for
- Food & beverage$4,894100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 60 | $1,620 |
| Neurocrine Biosciences, Inc. | 37 | $1,154 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $615 |
| Otsuka America Pharmaceutical, Inc. | 14 | $494 |
| Axsome Therapeutics, Inc. | 4 | $208 |
| Sunovion Pharmaceuticals Inc. | 10 | $203 |
| Alkermes, Inc. | 3 | $161 |
| Neuronetics, Inc. | 1 | $78 |
| Eisai Inc. | 6 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $73 |
| Lundbeck LLC | 4 | $70 |
| E.r. Squibb & Sons, L.L.C. | 3 | $64 |
| Merck | 3 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,894 in reported general payments places this provider in the 95th percentile of 81 psychiatry providers in Alaska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 20 | $325 |
| Escitalopram Oxalate | 21 | $127 |
| Pregabalin | 12 | $62 |
| Alprazolam | 12 | $43 |
| Zolpidem Tartrate | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Anchorage
- Alex OrtenAnchorage$116K
- Cleve ShireyAnchorage$846
- David SamsonAnchorage$665
- Robert LongAnchorage$634
- Deborah GurisAnchorage$612
- Eileen HaAnchorage$575
- Amber BentonAnchorage$516
- David TelfordAnchorage$419
- Ryan WallaceAnchorage$395
- Donna WestlakeAnchorage$343
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.